Status | Study |
Recruiting |
Study Name: Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Date: 2017-02-10 Interventions: Other: Retrospective Data Review Retrospective, uncontrolled pre- and post-test design in a case series |
Recruiting |
Study Name: Optimal HCTZ Cessation for Diagnosis of Hyperparathyroidism Condition: Hyperparathyroidism Date: 2015-10-27 Interventions: Procedure: HCTZ cessation Patients will stop taking their HCTZ for 3 months |
Recruiting |
Study Name: Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Date: 2015-08-14 Interventions: Drug: eplerenone eplerenone, t |
Completed |
Study Name: Association Between Serum Periostin Levels and Cortical Porosity in Patients With Secondary Hyperparathyroidism Condition: Hyperparathyroidism Date: 2015-08-13 Interventions: Device: HR-pQCT The Xtrem CT s |
Recruiting |
Study Name: Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions? Condition: Primary Hyperparathyroidism Date: 2014-08-17 Interventions: Drug: Cinacalcet Cinacalcet, M |
Completed |
Study Name: Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis Condition: Secondary Hyperparathyroidism Date: 2014-05-14 Interventions: Drug: KHK7580 Oral administration |
Completed |
Study Name: A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis Condition: Secondary Hyperparathyroidism Date: 2014-04-29 Interventions: Drug: ASP7991 oral |
Completed |
Study Name: Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis Condition: Hyperparathyroidism Date: 2013-09-02 Interventions: Drug: KHK7580 Oral administration |
Completed |
Study Name: Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide Condition: Hyperparathyroidism, Secondary Date: 2013-08-28 Interventions: Drug: Etelcalcetide Etelcalcetide is provided as a sterile lyophilized powder to be reconstituted with s |
Completed |
Study Name: OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Date: 2013-06-21 Interventions: Drug: Sedron (alendronate) Oth |